Nichol Ochsner | Vice President of Investor Relations |
Rob Finizio | Chief Executive Officer |
James D'Arecca | Chief Financial Officer |
Dawn Halkuff | Chief Commercial Officer |
Mitchell Krassan | Chief Strategy & Performance Officer |
Dana Flanders | Guggenheim Partners |
Douglas Tsao | H.C. Wainwright |
Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD First Quarter 2021 Financial Results Conference Call.
Following prepared remarks from the company, we will open the call for questions. I would now like to turn the call over to TherapeuticsMD's Vice President of Investor Relations, Nichol Ochsner. Nichol?